# Hikma signs exclusive licensing and distribution agreement with Orion for Easyhaler inhaler

Hikma Pharmaceuticals signed an exclusive licensing and distribution agreement with Orion Corporation to register, distribute, market and sell Orion's Easyhaler inhaler (budesonide/formoterol) for asthma and COPD in all of Hikma's MENA markets.

- Type: Contract
- Announced: 2017-02-13
- Status: announced
- Products: Easyhaler inhaler, budesonide/formoterol dry powder inhaler
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Hikma Pharmaceuticals](https://endata.com/companies/22160.md)
- [Orion Corporation](https://endata.com/companies/22161.md) (supplier)

## Sources

- [pharmaceuticaldaily.com](https://pharmaceuticaldaily.com/hikma-won-exclusive-licensing-and-distribution-agreement-for-pulmonary-disease-drug/), 2017-02-13: "We are pleased to be adding this important product to our respiratory pipeline and we hope this collaboration with Orion will be the beginning of a long partnership for its Easyhaler device products in the MENA region."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.